Hepatitis: Difference between revisions
Jump to navigation
Jump to search
| Line 29: | Line 29: | ||
==Treatment== | ==Treatment== | ||
[[Hepatitis medical therapy|Medical Therapy]] | [[Hepatitis surgery|Surgery]] | [[Hepatitis primary prevention|Primary Prevention]] | [[Hepatitis secondary prevention|Secondary Prevention]] | [[Hepatitis cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[Hepatitis future or investigational therapies|Future or Investigational Therapies]] | [[Hepatitis medical therapy|Medical Therapy]] | [[Hepatitis surgery|Surgery]] | [[Hepatitis primary prevention|Primary Prevention]] | [[Hepatitis secondary prevention|Secondary Prevention]] | [[Hepatitis cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[Hepatitis future or investigational therapies|Future or Investigational Therapies]] | ||
====Contraindicated medications==== | |||
{{MedCondContrAbs|MedCond = Acute hepatitis|Methyldopa}} | |||
==Case Studies== | ==Case Studies== | ||
Revision as of 16:06, 9 September 2014
For patient information click here.
|
Hepatitis Main Page |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Hepatitis from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms | Physical Examination | Laboratory Findings | CT | MRI | Ultrasound | Other Imaging Findings | Other Diagnostic Studies
Treatment
Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies
Contraindicated medications
Acute hepatitis is considered an absolute contraindication to the use of the following medications: